Search results
Results From The WOW.Com Content Network
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, in the United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products.
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois.It is ranked sixth on the list of largest biomedical companies by revenue.In 2023, the company's seat in Forbes Global 2000 was 74, [2] and rank 89 on the 2024 list. [3]
Hospira was an American global pharmaceutical and medical device company with headquarters in Lake Forest, Illinois.It had approximately 19,000 employees. [1] Before its acquisition by Pfizer, Hospira was the world's largest producer of generic injectable pharmaceuticals, [2] manufacturing generic acute-care and oncology injectables, as well as integrated infusion therapy and medication ...
Abbott Laboratories – Wallace Calvin Abbott (1888) Abercrombie & Fitch – David T. Abercrombie and Ezra Fitch; ... Brooks Locomotive Works – founded by Horatio G ...
2. Abbott Laboratories. Abbott Laboratories (NYSE: ABT) is a well-diversified healthcare company, with four distinct units: Medical devices, diagnostics, nutrition, and established pharmaceuticals ...
A year after the American Academy of Pediatrics flagged what it described as "questionable marketing practices" by makers of formulas for older infants and toddlers, Abbott Laboratories is being ...
St. Jude Medical was founded in 1976 and went public in 1977, [4] [5] and the company has been listed in the Fortune 500 every year since 2010. [6] The company was acquired by Abbott Laboratories in January 2017. [7] [8] Michael T. Rousseau served as the company's president and chief executive officer from 2016 until its acquisition by Abbott. [9]
Abbott Laboratories is also an excellent dividend stock, currently on a streak of 52 consecutive payout increases. If you opt to reinvest the dividend -- currently yielding 1.8% -- you'll see ...